FDA Peptide Update: Category 2 Removals Explained Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA Announces Removal of 12 Peptides from Category 2 and Schedules PCAC Meetings to Consider Adding Peptides to 503A Bulk Drug Substances List FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy